Related Experiment Video
Updated: May 31, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
[Comprehensive treatment for type 2 diabetes mellitus]
1Key Laboratory of Endocrinology of Ministry of Health, Department of Endocrinology, PUMC Hospital,CAMS and PUMC, Beijing 100730, China.
Summary
Managing type 2 diabetes mellitus involves more than just blood sugar control. Comprehensive strategies including blood pressure, lipid management, aspirin, and even surgery are crucial for better patient outcomes.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Disease Management
- Surgical Interventions
Background:
- Traditional type 2 diabetes mellitus (T2DM) treatment primarily targets glycemic control.
- Emerging evidence highlights the importance of a multifaceted approach for T2DM management.
- Holistic care is essential for improving long-term T2DM patient outcomes.
Purpose of the Study:
- To review the evolving landscape of type 2 diabetes mellitus treatment.
- To emphasize the significance of comprehensive management strategies beyond glycemic control.
- To discuss the role of novel therapeutic avenues in T2DM care.
Main Methods:
- Literature review of current T2DM treatment guidelines and research.
- Analysis of studies focusing on integrated management of hyperglycemia, hypertension, and dyslipidemia.
- Inclusion of data on the impact of antiplatelet therapy and bariatric surgery in T2DM.
Main Results:
- Glycemic control remains a cornerstone but is insufficient alone for optimal T2DM outcomes.
- Blood pressure management and antihyperlipidemic agents (e.g., statins) significantly improve cardiovascular outcomes in T2DM patients.
- Aspirin use and surgical interventions like stomach reduction surgery are increasingly recognized as valuable components of T2DM management.
Conclusions:
- Comprehensive management, integrating glycemic, blood pressure, and lipid control, is vital for T2DM.
- Pharmacological and surgical interventions offer additional benefits for improving T2DM patient prognosis.
- A personalized, multi-pronged treatment strategy is essential for effective type 2 diabetes mellitus care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...